Skip to main content
Steve Chin, MD, Hematology, Charleston, SC, Providence Veterans Affairs Medical Center

SteveHsukwoChinMD

Hematology Charleston, SC

Assistant Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina College of Medicine

Dr. Chin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chin's full profile

Already have an account?

Education & Training

  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine/Psychiatry, 2000 - 2005
  • Spartan Health Sciences University
    Spartan Health Sciences UniversityClass of 1998

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2005 - 2022
  • SC State Medical License
    SC State Medical License 2009 - 2015

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of First-in-Class Anti-CD39xTGF-Β Bispecific Antibody ES014
    Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of First-in-Class Anti-CD39xTGF-Β Bispecific Antibody ES014February 27th, 2023
  • Elpiscience Announces CDE IND Clearance of ES014, a First in Class Anti-CD39xTGF-Β Bispecific Antibody for Patients with Advanced Solid Tumors
    Elpiscience Announces CDE IND Clearance of ES014, a First in Class Anti-CD39xTGF-Β Bispecific Antibody for Patients with Advanced Solid TumorsDecember 22nd, 2022
  • CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsOctober 8th, 2021

Professional Memberships

Hospital Affiliations